Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.3% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
36
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.9% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
14 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
43.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Syndax Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Advances In Precision Medicine Will Transform Oncology Markets
Key Takeaways Exceptionally rapid uptake and extended therapy duration for lead products position the company for accelerated revenue growth and significantly improved earnings and profitability horizons. Strong patent protection and pipeline innovation secure long-term market leadership, premium pricing, and expanded opportunities in precision medicine and chronic oncology.
View narrative
US$56.00
FV
72.0% undervalued
intrinsic discount
121.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
XLSMART Telecom Sejahtera
AN
AnalystLowTarget
Consensus Narrative from 21 Analysts
Escalating Spectrum Auctions And Tech Risks Will Strain Margins
Key Takeaways Escalating regulatory and technology risks threaten margins, elevate capital costs, and may render recent investments less valuable in the long term. Intensifying competition, stalled subscriber growth, and merger execution challenges jeopardize revenue stability while exposing the company to integration and profitability pressures.
View narrative
Rp1.63k
FV
80.3% overvalued
intrinsic discount
10.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Planet Labs PBC
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
AI Integration And Climate Trends Will Advance Satellite Analytics
Key Takeaways The company's integrated, AI-driven analytics and rapid satellite innovation create a strong data moat and margin expansion, making its services indispensable across diverse sectors. Its unique positioning for real-time monitoring, flywheel contract model, and deep enterprise integration drive recurring revenue, wallet share, and long-term earnings growth.
View narrative
US$9.00
FV
21.6% undervalued
intrinsic discount
23.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Curaleaf Holdings
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Medical Cannabis Legalization And Wellness Trends Will Redefine Market Opportunities
Key Takeaways International expansion, innovation in medical devices, and proprietary brands position Curaleaf for significant gains in revenue, margin, and category leadership as global markets open. Operational efficiency, premium product offerings, and asset-light strategies underpin resilience, recurring growth, and outsized market share amid broad industry legalization and normalization.
View narrative
CA$4.51
FV
7.6% undervalued
intrinsic discount
4.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Alsea. de
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Rising Regulatory Pressures And Digital Competition Will Undercut Stability
Key Takeaways Regulatory pressures, digital competition, and franchise dependency are squeezing Alsea's margins and reducing its control over pricing and brand innovation. Currency volatility and high leverage are amplifying financial risks and threatening Alsea's ability to invest, adapt, or weather economic shocks.
View narrative
Mex$47.80
FV
13.6% overvalued
intrinsic discount
7.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Knaus Tabbert
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Dealer Caution Will Depress Vehicle Orders Yet Incite Modest Rebound
Key Takeaways Moderated dealer confidence and constrained production capacity may limit the company's ability to capitalize on growing demand and evolving travel preferences. Margin improvement and sustainable cash flow remain challenged by industry competition, limited operating leverage, and diminishing scope for further efficiency gains.
View narrative
€15.00
FV
14.0% overvalued
intrinsic discount
1.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Viasat
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Next Generation Constellation Will Empower Global Digital Inclusion
Key Takeaways Accelerated satellite deployment and shared infrastructure models are set to expand Viasat's addressable markets, diversify revenue streams, and enhance free cash flow. Leadership in open networks and data security positions Viasat for dominant roles in mobile broadband, defense, and government connectivity as digital demand grows.
View narrative
US$50.00
FV
43.6% undervalued
intrinsic discount
2.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Weave Communications
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Cloud Adoption Will Expand Integrated Communications Across SMB Sectors
Key Takeaways Deep system integrations and AI-driven automation are creating a strong competitive moat, driving higher retention, pricing power, and substantial margin expansion. Early-stage digital adoption among SMBs gives Weave the opportunity for sustained revenue growth, recurring earnings, and diversification beyond core healthcare.
View narrative
US$15.00
FV
49.2% undervalued
intrinsic discount
16.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Bodal Chemicals
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Operational Risks Will Hamper Prospects But Allow Cautious Recovery
Key Takeaways Diversification into new chemical segments offers potential, but execution risks, raw material volatility, and global trends threaten revenue stability and margin improvement. Efforts to reduce debt and capital expenditure may be offset by persistent high working capital requirements and stricter environmental compliance costs, constraining earnings growth.
View narrative
₹78.00
FV
15.4% undervalued
intrinsic discount
14.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies